DISEASE INDICATIONS: Duchenne Muscular Dystrophy
MANUFACTURER: Merrell Dow/Henning
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Medicines & Healthcare products Regulatory Agency (MHRA)
The Federal Institute for Drugs and Medical Devices (BfArM)
Calcort (deflazacort) is a versatile medication that is prescribed for the treatment of various conditions, including but not limited to asthma, arthritis, allergies, skin conditions, kidney disorders, heart conditions, digestive system issues, eye problems, blood disorders, and tumors. Additionally, it is used for the treatment of Duchenne muscular dystrophy (DMD).